Consortium International Holdings, LLC is a well-established US based entity that serves the growing and expanding needs in the worldwide fight against SARS-CoV-2 (Covid-19), and offers a complete line of diagnostic test devices for the detection of SARS-CoV-2 virus. These products include highly sensitive and specific Antigen and Antibody Covid-19 Rapid tests as well as Real-Time Molecular (PCR) and Readers. The most recent addition includes the new SARS-CoV-2  plus Influenza A/B Rapid test and a new and novel semi-quantitative Neutralizing Antibody Rapid test.

In additional to the line of diagnostics that we offer, Consortium International also offers a complete line of PCR Readers including the innovative, portable MA-1630Q Series Portable Real-Time Fluorescence Quantitative PCR Reader as well as the newly introduced MQ-4164 and the laboratory based Real Time Quantitative Thermal Cycler Reader. Also available to our international markets only outside of the USA, is the Diagnostic Virus Sample Tube with Swab for either nasopharyngeal or oropharyngeal sampling.

Our mission is to provide a complete system of high quality and reliable Covid-19 diagnostic test devices which target both professional providers and the public health markets where authorized for such distribution.  All products are produced under the highest quality standards delivering to our clients around the world, diagnostics that are reliable and can deliver repeatable test results.

      Note: Only those products that have the US FDA Emergency Use Authorization (EUA) are available for distribution within the United States.